About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Placement of Expandable Intratracheal Silicon Stent for Riedel’s Thyroiditis

citalopram and alcohol memory loss

citalopram and alcohol cravings click here
Ersin Gurkan DUMLU¹, Fahri YETISIR¹, Murat Baki YILDIRIM¹, Mehmet Tokaç¹, Ibrahim Kilinç¹, Sefika Burçak Polat², Tülin Gümüs³, Mehmet  KILIC4
From the Department of General Surgery1,  Department of General Endocrinology2, Department  of Anesthesiology3, Ataturk Research and Training Hospital, Ankara 06800, Turkey; Department of General Surgery4, Yildirim Beyazit University, Ankara 06800, Turkey.
Corresponding Author:
Dr. Ersin Gurkan DUMLU
Email: gurkandumlu@gmail.com
Received: 6 AUG 2013 Accepted: 4-SEP-2013 Published Online: 20-SEP-2013
DOI: http://dx.doi.org/10.17659/01.2013.0078
Abstract
Introduction: Riedel thyroiditis is a form of thyroiditis characterised by inflammatory proliferative fibrotic process leading to destruction of thyroid gland and its capsule until reaching the surrounding tissue. 
Case Report: Herein, the placement of intratracheal stent along with surgical treatment is discussed in a patient of Riedel thyroiditis with pressure symptoms and nonresponsive to medical treatment.
Discussion: Patients usually present with hard enlarged mass in the neck and pressure symptoms. Surgical treatment may be required when tracheal and esophageal pressure symptoms occur. Since Riedel thyroiditis involves surrounding tissues as well, it prevents a thyroidectomy at surgical anatomic plane and increases the probability of injury to recurrent laryngeal nerve and parathyroid glands.
Conclusion: When pressure symptoms recur in patients with Riedel thyroidits, who were operated previously, the placement of intratracheal permanent stent should be kept in mind among treatment options. 
Keywords : Thyroiditis, Thyroidectomy, Parathyroid Glands, Stents, Trachea.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 02, 2025